From: Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
 | Total number of examined eyes n = 20 | Age of the studied cases | Test of significance (between age groups) | |
---|---|---|---|---|
< 40 years n = 8 | ≥ 40 years n = 12 | |||
BCVA Before injection | ||||
 Mean ± S. D | 0.77 ± 0.28 | 0.88 ± 0.28 | 0.60 ± 0.21 | t1 = 2.56 |
 Range | 0.4–1.4 | 0.4–1.4 | 0.4–1 | p = 0.0197 |
BCVA After 6 months | ||||
 Mean ± S. D | 0.42 ± 0.24 | 0.48 ± 0.23 | 0.33 ± 0.24 | t1 = 1.392 |
 Range | 0.1–1 | 0.22–1 | 0.1–0.7 | p = 0.181 |
 t2 | 17.609 | 14.443 | 5.998 |  |
 P value | 0.001* | 0.001* | 0.028* |  |
CMT (um) Before injection | ||||
 Mean ± S. D | 247.95 ± 25.24 | 242.88 ± 23.83 | 251.33 ± 26.60 | t1 = 0.724 |
 Range | 212–289 | 212–289 | 213–287 | p = 0.478 |
CMT (um) After 6 months | ||||
 Mean ± S. D | 194.70 ± 16.11 | 191.13 ± 13.83 | 197.08 ± 17.64 | t1 = 0.802 |
 Range | 165–235 | 165–210 | 175–235 | p = 0.433 |
 t2 | 63.252 | 28.223 | 34.663 |  |
 P value | 0.001* | 0.001* | 0.001* |  |